BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 24618605)

  • 1. A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients.
    Doyle LA; Sepehr GJ; Hamilton MJ; Akin C; Castells MC; Hornick JL
    Am J Surg Pathol; 2014 Jun; 38(6):832-43. PubMed ID: 24618605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis.
    Hahn HP; Hornick JL
    Am J Surg Pathol; 2007 Nov; 31(11):1669-76. PubMed ID: 18059223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic mastocytosis mimicking inflammatory bowel disease: A case report and discussion of gastrointestinal pathology in systemic mastocytosis.
    Bedeir A; Jukic DM; Wang L; Mullady DK; Regueiro M; Krasinskas AM
    Am J Surg Pathol; 2006 Nov; 30(11):1478-82. PubMed ID: 17063092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are Enterocolic Mucosal Mast Cell Aggregates Clinically Relevant in Patients Without Suspected or Established Systemic Mastocytosis?
    Johncilla M; Jessurun J; Brown I; Hornick JL; Bellizzi AM; Shia J; Yantiss RK
    Am J Surg Pathol; 2018 Oct; 42(10):1390-1395. PubMed ID: 30001235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mastocytic enterocolitis: increased mucosal mast cells in chronic intractable diarrhea.
    Jakate S; Demeo M; John R; Tobin M; Keshavarzian A
    Arch Pathol Lab Med; 2006 Mar; 130(3):362-7. PubMed ID: 16519565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological characteristics of systemic mastocytosis in the intestine.
    Shih AR; Deshpande V; Ferry JA; Zukerberg L
    Histopathology; 2016 Dec; 69(6):1021-1027. PubMed ID: 27391777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis.
    Berezowska S; Flaig MJ; Ruëff F; Walz C; Haferlach T; Krokowski M; Kerler R; Petat-Dutter K; Horny HP; Sotlar K
    Mod Pathol; 2014 Jan; 27(1):19-29. PubMed ID: 23807778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal manifestations of systemic mastocytosis.
    Lee JK; Whittaker SJ; Enns RA; Zetler P
    World J Gastroenterol; 2008 Dec; 14(45):7005-8. PubMed ID: 19058339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased intestinal mucosal leptin levels in patients with diarrhea-predominant irritable bowel syndrome.
    Liu DR; Xu XJ; Yao SK
    World J Gastroenterol; 2018 Jan; 24(1):46-57. PubMed ID: 29358881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic mastocytosis involving the gastrointestinal tract: clinicopathologic and molecular study of five cases.
    Kirsch R; Geboes K; Shepherd NA; de Hertogh G; Di Nicola N; Lebel S; Mickys U; Riddell RH
    Mod Pathol; 2008 Dec; 21(12):1508-16. PubMed ID: 18931652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.
    Park JH; Rhee PL; Kim HS; Lee JH; Kim YH; Kim JJ; Rhee JC
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):71-8. PubMed ID: 16706815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performing colonic mast cell counts in patients with chronic diarrhea of unknown etiology has limited diagnostic use.
    Sethi A; Jain D; Roland BC; Kinzel J; Gibson J; Schrader R; Hanson JA
    Arch Pathol Lab Med; 2015 Feb; 139(2):225-32. PubMed ID: 25611105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome.
    Cremon C; Carini G; Wang B; Vasina V; Cogliandro RF; De Giorgio R; Stanghellini V; Grundy D; Tonini M; De Ponti F; Corinaldesi R; Barbara G
    Am J Gastroenterol; 2011 Jul; 106(7):1290-8. PubMed ID: 21427712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting.
    De Silva AP; Nandasiri SD; Hewavisenthi J; Manamperi A; Ariyasinghe MP; Dassanayake AS; Jewell DP; de Silva HJ
    Scand J Gastroenterol; 2012 Jun; 47(6):619-24. PubMed ID: 22486731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.
    Martínez C; Lobo B; Pigrau M; Ramos L; González-Castro AM; Alonso C; Guilarte M; Guilá M; de Torres I; Azpiroz F; Santos J; Vicario M
    Gut; 2013 Aug; 62(8):1160-8. PubMed ID: 22637702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are gastrointestinal mucosal mast cells increased in patients with systemic mastocytosis?
    Siegert SI; Diebold J; Ludolph-Hauser D; Löhrs U
    Am J Clin Pathol; 2004 Oct; 122(4):560-5. PubMed ID: 15487454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal manifestations in mastocytosis: a study of 83 patients.
    Sokol H; Georgin-Lavialle S; Canioni D; Barete S; Damaj G; Soucie E; Bruneau J; Chandesris MO; Suarez F; Launay JM; Aouba A; Grandpeix-Guyodo C; Lanternier F; Grosbois B; de Gennes C; Cathébras P; Fain O; Hoyeau-Idrissi N; Dubreuil P; Lortholary O; Beaugerie L; Ranque B; Hermine O
    J Allergy Clin Immunol; 2013 Oct; 132(4):866-73.e1-3. PubMed ID: 23890756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors.
    Lee KJ; Kim YB; Kim JH; Kwon HC; Kim DK; Cho SW
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1689-94. PubMed ID: 19120860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea.
    Sohn W; Lee OY; Lee SP; Lee KN; Jun DW; Lee HL; Yoon BC; Choi HS; Sim J; Jang KS
    Scand J Gastroenterol; 2014 Jan; 49(1):43-51. PubMed ID: 24256141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.